| Ytd | -35.20% | |
| 1y | -51.89% |
| Open | 1.36 | Prev Close | 1.45 | Low | 1.17 | High | 1.37 | Mkt Cap | 4.69M |
| Vol | 4.71M | Avg Vol | 3.22M | EPS | -2.07 | P/E | N/A | Forward P/E | -0.84 |
| Beta | 5.03 | Short Ratio | 0.56 | Inst. Own | 3.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 2.13 | 200-d Avg | 2.42 | 1yr Est | 30.00 |
CELZ News
Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se
Dear Fellow Shareholder:Creative Medical has entered the second half of 2026 with a strengthened cli
Highlights Significant Clinical, Regulatory, and Strategic Progress, Supported by a Disciplined Capi
Gainers Can Fite Biopharma (AMEX:CANF) stock moved upwards by 52.0% to $4.52 during Wednesday's
Constellation Brands (NYSE: STZ) rose in pre-market trading after reporting strong Q1 earnings and r
Gainers Alzamend Neuro (NASDAQ:ALZN) stock increased by 12.9% to $1.35 during Tuesday's after-m
PHOENIX, June 30, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc., (Nasdaq: CELZ
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#
US stocks traded higher, Nasdaq up 150 points. Dow up 0.02%, Nasdaq up 0.68%, S&P 500 up 0.28%.
US stocks mixed, Dow falls 0.2%. Leading sectors: tech up 1%, real estate down 1.4%. S&P 500 up
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday
Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 67.3% to $2.08 during Friday's regu
US stocks traded lower, Nasdaq fell 200 pts, Dow down 0.31%, S&P 500 dropped 0.50%. Health care
Gainers Quantum Cyber (NASDAQ:QUCY) stock moved upwards by 63.4% to $2.37 during Friday's pre-m
Synaptics Inc (SYNA) rose 5.6% in pre-market trading after announcing a merger with ON Semiconductor
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 66.9% to $6.31 during Thursda
Under the amended protocol, the Company is enrolling an additional 15 patients receiving less than 9
Creative Medical Tech (NASDAQ:CELZ) reported quarterly losses of $(0.38) per share which beat the an
Ultrasome™ Demonstrates Strong Clinical Signal While Leveraging GMP-Produced CELZ-201 (Olastrocel) t
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) ("Creative Medical" or the "Com
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ), a clinical-stage biotechnology company adv
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) ("Creative Medical" or the "Com
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) ("Creative Medical" or the "Com
https://x.com/patentgrants/status/1957532080155562158?s=46&t=dtUiyC3dUs5yGRgT9qYHWg
U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark
https://patentcenter.uspto.gov/applications/17559970/ifw/docs
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ), a leading biotechnology innovator in regen
Notably, over 90% of patients reported no opioid use for pain management three years post-procedure,
Results demonstrate that CELZ-201 achieved an 80% overall efficacy rate in reducing insulin dependen
Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Compan
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the comp
FDA approval under expanded access for Creative Medical. CELZ-201, a pioneering cell-based program,
Creative Medical Technology Holdings, Inc., (NASDAQ:CELZ), a leader in biotech innovation, today ann
CRWD: 27% | CrowdStrike Holdings shares are trading higher after the company reported better-than-ex